ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ANCA"

  • Abstract Number: 1664 • 2019 ACR/ARP Annual Meeting

    Reducing the Number of Rituximab Infusions at Onset of Maintenance Therapy for ANCA-associated Vasculitides: Results of a Post Hoc Analysis from a Randomized–controlled Trial

    Pierre Charles1, Agnes Dechartres 2, Benjamin Terrier 3, Pascal Cohen 3, Stanislas Faguer 4, Antoine Huart 4, Mohamed Hamidou 5, Christian Agard 5, Bernard Bonnotte 6, Maxime Samson 7, Alexandre Karras 8, Noémie Jourde-Chiche 9, François Lifermann 10, Pierre Gobert 11, Catherine Hanrotel-Saliou 12, Pascal Godmer 13, Nicolas Martin-Silva 14, Grégory Pugnet 15, Marie Matignon 16, Olivier Aumaitre 17, Jean-François Viallard 18, François Maurier 19, Nadine Meaux Ruault 20, Sophie Rivière 21, Jean Sibilia 22, Xavier Puéchal for the French Vasculitis Study Group 3, Luc Mouthon 3 and Loic Guillevin 3, 1Institut Mutualiste Montsouris, Paris, France, 2APHP, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin, Paris, France, 4CHU Toulouse, Toulouse, France, 5CHU Nantes, Nantes, France, 6Service de Médecine Interne et Immunologie Clinique, CHU Dijon Bourgogne, Hôpital François Mitterrand, Dijon ; Université Bourgogne-Franche Comté, INSERM, EFS BFC, UMR1098, F-21000 Dijon, Dijon, France, 7CHU Dijon, Dijon, France, 8Paris HEGP, Paris, France, 9APHM, Marseille, Marseille, France, 10CH Dax, Dax, France, 11CH Avignon, Avignon, France, 12CHU Brest, Brest, France, 13CH Bretagne-Atlantique, Vannes, France, 14CHU Caen, Caen, France, 15CHU de Toulouse, Hôpital Purpan, Service de Médecine Interne, Toulouse, France, 16APHP, Créteil, France, 17CHU Clermont Ferrand, Clermont Ferrand, France, 18CHU Bordeaux, Bordeaux, France, 19Service de Médecine Interne, Hôpital Belle Isle, Metz, Metz, France, 20CHU Besançon, Besançon, France, 21CHU Montpellier, Montpellier, France, 22CHU Strasbourg, Strasbourg, France

    Background/Purpose: Rituximab (RTX) superiority over azathioprine to maintain ANCA-associated vasculitis (AAV) remission was demonstrated.The MAINRITSAN2 trial was designed to compare an individually tailored RTX-infusion schedule…
  • Abstract Number: 2627 • 2019 ACR/ARP Annual Meeting

    Association of Work Productivity Assessed by Absenteeism and Presenteeism with Disease Activity, Damage and Health-related Quality of Life in Patients with ANCA-associated Vasculitis

    Shinya Hirahara1, Yasuhiro Katsumata 1, Ken-ei Sada 2, Hiroko Nagafuchi 3, Eiichi Tanaka 1 and Masayoshi Harigai 1, 1Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kitaku, Okayama, Japan, 3Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki City, Kanagawa, Japan

    Background/Purpose: Chronic inflammatory diseases such as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) substantially affects patients’ daily lives, including their ability to work. Although the management…
  • Abstract Number: 1665 • 2019 ACR/ARP Annual Meeting

    Glucocorticoids in Incident ANCA-Associated Vasculitis (AAV) Patients – A Study of Routine Clinical Practice in the EU Demonstrates Prolonged Use and Temporal Relationship to Adverse Events and Infections

    Dieter Goette1 and Peter Rutherford 1, 1Vifor Pharma, Zurich, Zurich, Switzerland

    Background/Purpose: AAV is a severe systemic vasculitis and rapid induction of remission is essential and  high dose glucocorticoids (GC) are part of standard of care.…
  • Abstract Number: 2628 • 2019 ACR/ARP Annual Meeting

    Mortality Predictors in ANCA-associated Vasculitis: Experience of a Brazilian Monocentric Cohort of a Rheumatology Center

    Marilia Dagostin1, Sergio Nunes 2, Samuel Shinjo 3 and Rosa Pereira 4, 1University of Sao Paulo, São Paulo, Brazil, 2Univeristy Of Sao Paulo, São Paulo, 3Univeristy Of Sao Paulo, São Paulo, Brazil, 4Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

    Background/Purpose: Mortality of patients with ANCA-associated vasculitis (AAV) is higher than the general population. There are few papers in the literature regarding the factors associated…
  • Abstract Number: L04 • 2018 ACR/ARHP Annual Meeting

    Pediatric Open-Label Clinical Study of Rituximab for the Treatment of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

    Paul Brogan1, Gavin Cleary2, Aimee O. Hersh3, Ozgur Kasapcopur4, Satyapal Rangaraj5, Rae S.M. Yeung6, Andrew Zeft7, Simone Melega8, Paul Brunetta9, Jennifer Cooper10, Pooneh Pordeli11 and Patricia B. Lehane12, 1Infection Inflammation and Rheumatology, UCL GOL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 2Alder Hey Children's Hospital, Liverpool, United Kingdom, 3Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 4Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey, 5Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom, 6Paediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 7Center for Pediatric Rheumatology & Immunology, The Cleveland Clinic Foundation, Cleveland, OH, 8F. Hoffmann-La Roche, Basel, Switzerland, 9Genentech, Inc., South San Francisco, CA, 10Pediatric Rheumatology, Univ. of California San Francisco, San Francisco, CA, 11Hoffmann-La Roche Ltd., Mississauga, ON, Canada, 12Roche Products Ltd., Welwyn Garden City, United Kingdom

    Background/Purpose: PePRS is a Phase IIa international, multicenter, open-label single arm study of rituximab in pediatric patients with newly diagnosed or relapsing GPA or MPA.…
  • Abstract Number: 1747 • 2018 ACR/ARHP Annual Meeting

    Long-Term Outcomes of Patients with Nonsevere Eosinophilic Granulomatosis with Polyangiitis Given Azathioprine and Glucocorticoids for Remission Induction

    Xavier Puéchal1, Christian Pagnoux2, Gabriel Baron3, François Lifermann4, Loïk Geffray5, Thomas Quémeneur6, Jean-Luc Saraux7, Marie Wislez8, Vincent Cottin9, Marc Ruivard10, Nicolas Limal11, Achille Aouba12, Bernard Bonnotte13, Antoine Neel14, Christian Agard15, Pascal Cohen16, Benjamin Terrier17, Claire Le Jeunne17, Luc Mouthon1, Philippe Ravaud3 and Loïc Guillevin for the French Vasculitis Study Group17, 1Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, 2Division of Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, 3Paris Hôtel Dieu, Paris, France, 4Dax, Dax, France, 5Lisieux, Lisieux, France, 6Department of Internal Medicine, CH of Valenciennes, France, Valenciennes, France, 7Eaubonne, Eaubonne, France, 8Paris Tenon, Paris, Gambia, 9Lyon Louis Pradel, Lyon, France, 10Clermont-Ferrand, Clermont Ferrand, France, 11Créteil Henri Mondor, Créteil, France, 12Caen, Caen, France, 13Dijon, Dijon, France, 14Medecine Interne, Nantes Hôtel Dieu, Nantes, France, 15Nantes Hôtel Dieu, Nantes, France, 16Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 17National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France

    Background/Purpose: At month 24 (M24), CHUSPAN2-trial patients with nonsevere eosinophilic granulomatosis with polyangiitis (EGPA), who received 1 yr of azathioprine (AZA) and glucocorticoids (GC) as…
  • Abstract Number: 1967 • 2018 ACR/ARHP Annual Meeting

    Detection of Association of Long Noncoding RNA ATP6V0E2-AS1 Single Nucleotide Polymorphism with Susceptibility to Myeloperoxidase-ANCA Associated Vasculitis Based on Transcriptome Analysis

    Yuka Iwahashi1,2, Aya Kawasaki1,2, Takayo Tsuchiura3, Ken-ei Sada4, Fumio Hirano5,6, Daisuke Tsukui7, Shigeto Kobayashi8, Hidehiro Yamada9, Hiroshi Furukawa1,2,10, Kenji Nagasaka11, Takahiko Sugihara12, Nao Nishida3, Kunihiro Yamagata13, Takayuki Sumida14, Shigeto Tohma10,15, Shoichi Ozaki9, Hiroshi Hashimoto16, Hirofumi Makino17, Yoshihiro Arimura18, Hajime Kono19, Masayoshi Harigai20 and Naoyuki Tsuchiya1,2, 1University of Tsukuba, Graduate School of Comprehensive Human Sciences, Masters' Program in Medical Sciences, Tsukuba, Japan, 2University of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan, 3Genome Medical Science Project, National Center for Global Health and Medicine, Research Center for Hepatitis and Immunology, Ichikawa, Japan, 4Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 5Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan, 6Tokyo Medical and Dental UniversityGraduate School of Medical and Dental Sciences, Department of Lifetime Clinical Immunology, Tokyo, Japan, 7Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 8Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 9St. Marianna University, School of Medicine, Department of Internal Medicine, Kawasaki, Japan, 10National Hospital Organization Sagamihara l Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan, 11Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, 12Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 13University of Tsukuba, Faculty of Medicine, Department of Nephrology, Tsukuba, Japan, 14Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 15National Hospital Organization Tokyo National Hospital, Kiyose, Japan, 16Juntendo University School of Medicine, Tokyo, Japan, 17Okayama University Hospital, Okayama, Japan, 18Kyorin University School of Medicine, First Department of Internal Medicine, Tokyo, Japan, 19Teikyo University School of Medicine, Department of Internal Medicine, Tokyo, Japan, 20Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: Because of the low prevalence, only three genome-wide association studies, all from the Caucasian populations, have been reported on ANCA-associated vasculitis (AAV) thus far;…
  • Abstract Number: 2738 • 2018 ACR/ARHP Annual Meeting

    A Randomized Phase 3 Trial Evaluating the Safety and Efficacy of Avacopan in Patients with New or Relapsing Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

    Peter A. Merkel1, David Jayne2, Thomas J. Schall3, Pirow Bekker3 and Jan Hillson3, 1Division of Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 3ChemoCentryx, Mountain View, CA

    A Randomized Phase 3 Trial Evaluating the Safety and Efficacy of Avacopan in Patients with New or Relapsing Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisPeter A. Merkel1, David…
  • Abstract Number: 1748 • 2018 ACR/ARHP Annual Meeting

    Interstitial Lung Disease in ANCA-Positive Vasculitis Patients

    Andy Abril1, Minkyung Kwon,2, Isabel Mira-Avendano3, Carlos Rojas4 and Andras Khoor5, 1Rheumatology, Mayo Clinic Florida, Jacksonville, FL, 2Pulmonary and Critical Care, Mayo Clinic, Jacksonville, FL, 3Pulmonary and Critical Care, Mayo Clinic Florida, Jacksonville, FL, 4Radiology, Mayo Clinic, Jacksonville, FL, 5Pathology, Mayo Clinic, Jacksonville, FL

    Background/Purpose: Rarely, ANCA-positive vasculitis patients are found to have interstitial lung disease (ILD). Clinical characteristics and prognosis are not well known in these patients. The…
  • Abstract Number: 2440 • 2018 ACR/ARHP Annual Meeting

    Outcomes of Pregnancy Complicated By ANCA-Associated Vasculitis: A Retrospective Review

    Jennifer Strouse1, Melissa Swee2, Manish Suneja1 and Bharat Kumar3, 1Internal Medicine, University of Iowa, Iowa City, IA, 2Transplant Nephrology, University of Iowa, Iowa City, IA, 3Internal Medicine-Division of Immunology, University of Iowa, Iowa City, IA

    Background/Purpose: ANCA-Associated Vasculitis (AAV) is a small-vessel vasculitis that predominantly affects the kidneys, lungs, and sinuses, among other organs. It has been traditionally associated with…
  • Abstract Number: 2739 • 2018 ACR/ARHP Annual Meeting

    Systemic Vasculitis: Incidence of Glucocorticoid Related Adverse Events

    Luciano Fernando Lo Giudice1, Marina Scolnik2, Jose Maximiliano Martinez P3, Aurelia Luissi1, Valeria Scaglioni2 and Enrique R Soriano2, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Capital Federal, Argentina, 2Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, 3Rheumatology, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: The glucocorticoid toxicity index (GTI) (Miloslavsky et al. Ann Rheum Dis 2017) is useful to assess impact on morbility associated with these drugs. It…
  • Abstract Number: 1750 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Factor Titer Is Inversely Correlated with ANCA Titer and Relates to Characteristic Manifestations in Patients with Eosinophilic Granulomatosis with Polyangiitis

    Jun Inamo, Yuko Kaneko, Yuichiro Ota and Tsutomu Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), which is characterized by vasculitis with allergic features such as…
  • Abstract Number: 2718 • 2018 ACR/ARHP Annual Meeting

    Comparison of Various ANCA Detection Methods in Predominantly MPO ANCA-Associated Vasculitis Cohort

    Yasuhiro Katsumata1, Ken-ei Sada2, Tomohiro Kameda3, Hiroaki Dobashi3, Hisashi Yamanaka4 and Masayoshi Harigai5, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama, Japan, 3Internal Medicine Division of Hematology, Rheumatology, and Respiratory Medicine, Kagawa University, Kagawa, Japan, 4Institute of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 5Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: In 2017, the multicenter European Vasculitis Study Group (EUVAS) evaluated the diagnostic accuracy of a wide spectrum of detection tests of MPO and PR3-ANCAs…
  • Abstract Number: 2743 • 2018 ACR/ARHP Annual Meeting

    Favorable Efficacy of Rituximab in ANCA-Associated Vasculitis Patients with Excessive B Cell Differentiation

    Yusuke Miyazaki1, Shingo Nakayamada1, Satoshi Kubo1, Kazuhisa Nakano1, Shigeru Iwata2, Shunsuke Fukuyo3, Akio Kawabe4 and Yoshiya Tanaka5, 1First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health, Japan, Fukuoka, Japan, 4University of Occupational and Environmental Health, Japan, Kitakyusyu, Japan, 5University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose: B cell depletion by rituximab (RTX)is effective treatment for ANCA-associated vasculitis (AAV). However, the phenotype of peripheral B cells and the selection criteria for…
  • Abstract Number: 1751 • 2018 ACR/ARHP Annual Meeting

    Interstitial Lung Disease during ANCA-Associated Vasculitis: A Poor-Prognosis Factor

    Thibault Maillet1, Tiphaine Goletto2, Guillaume Beltramo3, Henry Dupuy4, Stéphane Jouneau5, Raphaël Borie6, Bruno Crestani6, Vincent Cottin7, Daniel Blockmans8, Estibaliz Lazaro4, Jean-Marc Naccache9, Grégory Pugnet10, Hilario Nunes11, Mathilde De Menthon12, Hervé Devilliers13, Philippe Bonniaud3, Xavier Puéchal14, Luc Mouthon14, Bernard Bonnotte1, Loïc Guillevin15, Benjamin Terrier14 and Maxime Samson1, 1Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France, 2Service de Pneumologie, Hôpital Saint-Louis, APHP, Paris, France, 3Service de Pneumologie, CHU de Dijon, Dijon, France, 4Service de Médecine Interne et Maladies Infectieuses, Hôpital Haut-Lévêque, Bordeaux, France, 5Service de Pneumologie, CHU de Rennes; IRSET UMR 1085, Université de Rennes 1, Rennes, France, 6Service de Pneumologie, Hôpital Bichat, APHP, Paris, France, 7Service de Pneumologie, Hôpital Louis-Pradel, Bron, France, 8Rheumatology, UZ Leuven, Leuven, Belgium, 9Service de Pneumologie, Hôpital Tenon, APHP, Paris, France, 10Service de Médecine Interne, CHU de Toulouse, Toulouse, France, 11Pulmonary diseases department, Avicenne Hospital (AP-HP), Bobigny, France, 12Service de Médecine Interne, Hôpital Bicêtre, APHP, Le Kremlin-Bicêtre, France, 13Service de Médecine Interne et Maladies Systémiques, CHU de Dijon, Dijon, France, 14Centre de Référence des Maladies Auto-immunes et Systémiques Rares, Vascularites Nécrosantes et Sclérodermie Systémique, Service de Médecine Interne, Hôpital Cochin, APHP, INSERM U1016, Université Paris Descartes, Paris, France, 15Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France

    Background/Purpose: Interstitial lung disease (ILD), rarely described in ANCA-associated vasculitis (AAV) patients, was mainly associated with anti-MPO ANCA. ILD’s prognostic value remains unclear. This study…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology